The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cross-sectional observational study to describe the clinicopathological and biological characteristics and the management of patients with HER2+ metastatic breast cancer who experienced complete or partial remission or disease stabilization during at least 3 years: LongHer study.
Pilar Zamora
No relevant relationships to disclose
Juan Angel Fresno-Vara
No relevant relationships to disclose
Angelo Gámez-Pozo
No relevant relationships to disclose
Ramon Perez-Carrion
No relevant relationships to disclose
Luis Manso
No relevant relationships to disclose
Carmen Crespo Massieu
No relevant relationships to disclose
Cesar Mendiola
No relevant relationships to disclose
Isabel Alvarez
No relevant relationships to disclose
Mireia Margeli Vila
No relevant relationships to disclose
Juan Lucas Bayo Calero
No relevant relationships to disclose
Xavier Gonzalez
No relevant relationships to disclose
Ana Santaballa
No relevant relationships to disclose
Eva Maria Ciruelos Gil
No relevant relationships to disclose
Ruth Afonso Gomez
No relevant relationships to disclose
Juan Lao Romera
No relevant relationships to disclose
Gustavo Catalan
No relevant relationships to disclose
Jose Valero Alvarez Gallego
No relevant relationships to disclose
Jose Miramon Lopez
No relevant relationships to disclose
Francisco Javier Salvador Bofill
No relevant relationships to disclose
Manuel Ruiz Borrego
No relevant relationships to disclose